Dignass, Axel U <br/><br/>
Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis.  [electronic resource] 

 -  Scandinavian journal of gastroenterology  Feb 2019 
 - 178-187 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>1502-7708 
<br/><br/><label>Standard No.: </label>10.1080/00365521.2019.1569124  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Biological Products--therapeutic use<br/>Colitis, Ulcerative--drug therapy<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome